Koch Industries’s LeMaitre Vascular LMAT Stock Holding History

Koch Industries’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-5,798	Closed	-$217K	–	726
2017 Q3	$217K	Buy	+5,798	New	+$197K	0.05%	403

Other funds holding LMAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EIP

Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

TAM

THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return

Koch Industries's LMAT Position: Q4 2017 in Review

Koch Industries sold out of LeMaitre Vascular (LMAT) in Q4 2017, closing a stake of 5,798 shares — an estimated $217K sold.

Koch Industries first reported a position in LMAT in Q3 2017 and held it in 1 quarter. The position peaked at $217K in Q3 2017. 142 funds tracked by Wall St. Rank hold LMAT as of Q4 2017.

Koch Industries reported no remaining LeMaitre Vascular position as of Q4 2017 after selling out during the quarter.
Koch Industries sold 5,798 LeMaitre Vascular shares in Q4 2017, an estimated $217K.
Koch Industries first reported a position in LeMaitre Vascular in Q3 2017 and held it in 1 quarter.
Koch Industries's LeMaitre Vascular position peaked at $217K in Q3 2017.
142 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q4 2017.

Based on Koch Industries's 13F filing for Q4 2017, filed 13 Feb 2018.